Purchase of Agilent 4150 Tape Station

The Food and Drug Administration is forecasting the purchase of an Agilent 4150 Tape Station instrument to integrate into its existing whole genome sequencing DNA and sample preparation workflows. This acquisition is intended to enhance the precision and efficiency of sample quality control in genomic research and regulatory testing. The instrument will be used to assess DNA integrity, fragment size, and concentration to support high-throughput sequencing operations critical to the agency’s scientific and compliance missions. The procurement is classified under NAICS code 334516, indicating it falls within the manufacture of laboratory machinery and equipment. The official point of contact for program inquiries is the Hfp Acquisition Liaison, reachable via hfpacquisitions@fda.hhs.gov, while the contracting officer position is currently listed as to be determined. No set-aside designation has been indicated, and the place of performance details are unspecified. The forecast was published on May 25, 2026, and interested parties can find additional information on the HHS OSDBU procurement portal.